REG - NewDay Funding Mstr - Statement re Prospectus
RNS Number : 3433HNewDay Funding Master Issuer PLC02 December 2020Company Announcement
NewDay Funding Master Issuer plc
2 December 2020
Information in the base prospectus dated 2 December 2020 (the "Base Prospectus") may be addressed to and/or targeted at persons who are residents of particular jurisdictions (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these jurisdictions and/or to whom the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
THIS NOTICE DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, AN OFFER FOR SALE, EXCHANGE OR SUBSCRIPTION OF, OR A SOLICITATION OF ANY OFFER TO BUY, EXCHANGE OR SUBSCRIBE FOR, ANY SECURITIES OF THE ISSUER OR ANY OTHER ENTITY IN ANY JURISDICTION.
COMPANY ANNOUNCEMENT
For Immediate Release 2 December 2020
NEWDAY FUNDING MASTER ISSUER PLC
1 Bartholomew Lane
LondonEC2N 2AX
Registered number 12586525
(the "Issuer")
PUBLICATION OF A BASE PROSPECTUS
The following base prospectus (the "Base Prospectus") of the Issuer has been approved by the Financial Conduct Authority:
Base Prospectus dated 2 December 2020 relating to NewDay Funding Master Issuer plc's Asset Backed Note Programme
The Base Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Contact Details:
Issuer:
1 Bartholomew Lane
London EC2N 2AX
Email: directors-uk@intertrustgroup.com
Attention: The Directors
This announcement is made byNEWDAY FUNDING MASTER ISSUER PLC
as Issuer
Dated 2 December 2020
LEI: 213800GBPRAJHSB5YK19
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDPDIFSLFWEESSEEE
Recent news on Maximus
See all newsRCS - URA Holdings PLC - Final Results
AnnouncementRCS - Escher Marwick PLC - Escher Marwick Plc Company Announcement
AnnouncementREG - HANetf ICAV - Notice to Shareholders
AnnouncementREG - JPMorgan ETFs (Ire.) - Dividends
AnnouncementRCS - GLO Capital PLC - GLO Capital Plc Company Announcement
Announcement